A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Tolerability of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome

STUDY OBJECTIVE: To evaluate the efficacy and tolerability of gabapentin enacarbil (GEn) 1200 mg or 600 mg compared with placebo in subjects with moderate-to-severe primary restless legs syndrome (RLS). METHODS: This 12-week, multicenter, double-blind, placebo-controlled study randomized subjects (1...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Lee, Daniel O., Ziman, Ronald B., Perkins, A. Thomas, Poceta, J. Steven, Walters, Arthur S., Barrett, Ronald W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Academy of Sleep Medicine 2011
Ämnen:
New Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3113968/
https://ncbi.nlm.nih.gov/pubmed/21677899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5664/JCSM.1074
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk